Cargando…

Evaluation of Hippo Pathway and CD133 in Radiation Resistance in Small-Cell Lung Cancer

Although the Hippo pathway and CD133 have been reported to play pertinent roles in a variety of cancer, knowledge about their contribution to radiation resistance in small-cell lung cancer (SCLC) is limited. In this first-of-a-kind study, we have reported the expression of key Hippo pathway proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Kui, Zhao, Yang, Du, Yonghao, Tang, Ruixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817273/ https://www.ncbi.nlm.nih.gov/pubmed/33519935 http://dx.doi.org/10.1155/2021/8842554

Ejemplares similares

YAP1 promotes multidrug resistance of small cell lung cancer by CD74‐related signaling pathways
por: Song, Yongchun, et al.
Publicado: (2019)

WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway
por: Tang, Ruixiang, et al.
Publicado: (2016)

Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
por: Lu, Ruiqi, et al.
Publicado: (2019)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

The role of Hippo pathway in ferroptosis
por: Xiang, Jiangxia, et al.
Publicado: (2023)

The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
por: Hsu, Ping-Chih, et al.
Publicado: (2020)

The Hippo Signaling Pathway in Drug Resistance in Cancer
por: Zeng, Renya, et al.
Publicado: (2021)

Hippo Pathway in Regulating Drug Resistance of Glioblastoma
por: Casati, Giacomo, et al.
Publicado: (2021)

The Hippo Pathway: Immunity and Cancer
por: Taha, Zaid, et al.
Publicado: (2018)

IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation
por: Chen, Yuhchyau, et al.
Publicado: (2015)

IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer
por: Lee, Soo Ok, et al.
Publicado: (2015)

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

The Hippo Pathway and Viral Infections
por: Wang, Zhilong, et al.
Publicado: (2020)

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
por: Wu, Shiwu, et al.
Publicado: (2012)

The role of non-canonical Hippo pathway in regulating immune homeostasis
por: Tang, Dagang, et al.
Publicado: (2023)

Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis
por: Sarmasti Emami, Sahar, et al.
Publicado: (2020)

Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

CD133 expression in chemo-resistant Ewing sarcoma cells
por: Jiang, Xiaohua, et al.
Publicado: (2010)

Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway
por: Zhao, Xiaoguang, et al.
Publicado: (2018)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Hippo signaling pathway and respiratory diseases
por: Tang, Weifeng, et al.
Publicado: (2022)

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma
por: Thirusangu, Prabhu, et al.
Publicado: (2022)

A comprehensive evaluation of Hippo pathway silencing in sarcomas
por: Merritt, Nicole M., et al.
Publicado: (2018)

Targeting the Hippo Pathway for Breast Cancer Therapy
por: Wu, Liqing, et al.
Publicado: (2018)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

Retraction Note to: IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation
por: Chen, Yuhchyau, et al.
Publicado: (2022)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

The Hippo pathway and cancer immunity: friend or foe?
por: Janse van Rensburg, Helena J, et al.
Publicado: (2018)

The Hippo signaling pathway: from multiple signals to the hallmarks of cancers: Hippo pathway: from multiple signals to the hallmarks of cancers
por: Zhu, Ning, et al.
Publicado: (2023)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Prostate Cancer Stem Cells: The Role of CD133
por: Yang, Jianhui, et al.
Publicado: (2022)

The Hippo pathway mediates Semaphorin signaling
por: Meng, Zhipeng, et al.
Publicado: (2022)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Upstream regulators of the Hippo pathway
por: Yu, Fa-Xing, et al.
Publicado: (2012)

Mechanisms of Hippo pathway regulation
por: Meng, Zhipeng, et al.
Publicado: (2016)

The Hippo Pathway in Prostate Cancer
por: Salem, Omar, et al.
Publicado: (2019)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tajtokrses64n3ag5i53ed8k9q